Flavell J, Nestor P
PCN Rep. 2024; 3(2):e210.
PMID: 38887313
PMC: 11180949.
DOI: 10.1002/pcn5.210.
Liu S, Jiang Z, Zhao J, Li Z, Li R, Qiu Y
Front Aging Neurosci. 2023; 15:1249512.
PMID: 37744388
PMC: 10512741.
DOI: 10.3389/fnagi.2023.1249512.
Bhatia-Dey N, Heinbockel T
Int J Environ Res Public Health. 2021; 18(13).
PMID: 34209997
PMC: 8297221.
DOI: 10.3390/ijerph18136976.
Spooner A, Chen E, Sowmya A, Sachdev P, Kochan N, Trollor J
Sci Rep. 2020; 10(1):20410.
PMID: 33230128
PMC: 7683682.
DOI: 10.1038/s41598-020-77220-w.
Etievant A, Monnin J, Lihoreau T, Tamadazte B, Rougeot P, Magnin E
Front Neuroanat. 2020; 14:34.
PMID: 32760253
PMC: 7371997.
DOI: 10.3389/fnana.2020.00034.
Olfactory Dysfunction in Familial and Sporadic Parkinson's Disease.
Chase B, Markopoulou K
Front Neurol. 2020; 11:447.
PMID: 32547477
PMC: 7273509.
DOI: 10.3389/fneur.2020.00447.
Endocannabinoid-Mediated Neuromodulation in the Olfactory Bulb: Functional and Therapeutic Significance.
Bhatia-Dey N, Heinbockel T
Int J Mol Sci. 2020; 21(8).
PMID: 32325875
PMC: 7216281.
DOI: 10.3390/ijms21082850.
Intact global cognitive and olfactory ability predicts lack of transition to dementia.
Devanand D, Lee S, Luchsinger J, Andrews H, Goldberg T, Huey E
Alzheimers Dement. 2019; 16(2):326-334.
PMID: 31676234
PMC: 7007828.
DOI: 10.1016/j.jalz.2019.08.200.
Emotion recognition in objects in patients with neurological disease.
Shiota M, Simpson M, Kirsch H, Levenson R
Neuropsychology. 2019; 33(8):1163-1173.
PMID: 31478721
PMC: 6823118.
DOI: 10.1037/neu0000587.
Olfactory impairment in frontotemporal dementia: A systematic review and meta-analysis.
Moraes E Silva M, Viveiros C, Kotsifas N, Duarte A, Dib E, Mercer P
Dement Neuropsychol. 2019; 13(2):154-161.
PMID: 31285789
PMC: 6601313.
DOI: 10.1590/1980-57642018dn13-020003.
Olfactory dysfunction in Alzheimer's disease Systematic review and meta-analysis.
Moraes E Silva M, Mercer P, Witt M, Pessoa R
Dement Neuropsychol. 2018; 12(2):123-132.
PMID: 29988355
PMC: 6022986.
DOI: 10.1590/1980-57642018dn12-020004.
Olfactory Testing in Frontotemporal Dementia: A Literature Review.
Tonacci A, Billeci L
Am J Alzheimers Dis Other Demen. 2018; 33(6):342-352.
PMID: 29742909
PMC: 10852515.
DOI: 10.1177/1533317518775037.
Reward deficits in behavioural variant frontotemporal dementia include insensitivity to negative stimuli.
Perry D, Datta S, Sturm V, Wood K, Zakrzewski J, Seeley W
Brain. 2017; 140(12):3346-3356.
PMID: 29053832
PMC: 5841034.
DOI: 10.1093/brain/awx259.
Progressive modulation of the human olfactory bulb transcriptome during Alzheimer´s disease evolution: novel insights into the olfactory signaling across proteinopathies.
Lachen-Montes M, Zelaya M, Segura V, Fernandez-Irigoyen J, Santamaria E
Oncotarget. 2017; 8(41):69663-69679.
PMID: 29050232
PMC: 5642507.
DOI: 10.18632/oncotarget.18193.
The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases.
Rey N, Wesson D, Brundin P
Neurobiol Dis. 2016; 109(Pt B):226-248.
PMID: 28011307
PMC: 5972535.
DOI: 10.1016/j.nbd.2016.12.013.
Assessment of Olfactory Function in MAPT-Associated Neurodegenerative Disease Reveals Odor-Identification Irreproducibility as a Non-Disease-Specific, General Characteristic of Olfactory Dysfunction.
Markopoulou K, Chase B, Robowski P, Strongosky A, Narozanska E, Sitek E
PLoS One. 2016; 11(11):e0165112.
PMID: 27855167
PMC: 5113898.
DOI: 10.1371/journal.pone.0165112.
Olfactory dysfunction in dementia.
Alves J, Petrosyan A, Magalhaes R
World J Clin Cases. 2014; 2(11):661-7.
PMID: 25405189
PMC: 4233420.
DOI: 10.12998/wjcc.v2.i11.661.
Odor identification in frontotemporal lobar degeneration subtypes.
Magerova H, Vyhnalek M, Laczo J, Andel R, Rektorova I, Kadlecova A
Am J Alzheimers Dis Other Demen. 2014; 29(8):762-8.
PMID: 24939002
PMC: 10852957.
DOI: 10.1177/1533317514539033.
The predictors of parent reported behaviors related to olfactory information processing in children with ADHD.
Ghanizadeh A
Psychiatry Investig. 2010; 7(2):116-21.
PMID: 20577620
PMC: 2890865.
DOI: 10.4306/pi.2010.7.2.116.
Should olfactory dysfunction be used as a biomarker of Alzheimer's disease?.
Wesson D, Wilson D, Nixon R
Expert Rev Neurother. 2010; 10(5):633-5.
PMID: 20420483
PMC: 3629552.
DOI: 10.1586/ern.10.33.